Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Niven

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapeutic Delivery|May 8, 2013
Prospects and challenges: inhalation delivery systemsRalph Niven
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 12, 2011
Safety and toxicology of cyclosporine in propylene glycol after 9-month aerosol exposure to beagle dogsRalph Niven, Maryellen Lynch, Ronald Moutvic, et al.
Pediatric Pulmonology|July 28, 2006
KL4-surfactant prevents hyperoxic and LPS-induced lung injury in micePaul Kinniry, Jeremy Pick, Scott Stephens, et al.
ERJ Open Research|March 16, 2023
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose studyHunter Gillies, Ralph Niven, Benjamin T Dake, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapeutic Delivery|May 8, 2013
Prospects and challenges: inhalation delivery systemsRalph Niven
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 12, 2011
Safety and toxicology of cyclosporine in propylene glycol after 9-month aerosol exposure to beagle dogsRalph Niven, Maryellen Lynch, Ronald Moutvic, et al.
Pediatric Pulmonology|July 28, 2006
KL4-surfactant prevents hyperoxic and LPS-induced lung injury in micePaul Kinniry, Jeremy Pick, Scott Stephens, et al.
ERJ Open Research|March 16, 2023
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose studyHunter Gillies, Ralph Niven, Benjamin T Dake, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertensionNicholas S Hill, Hunter Gillies, Murali M Chakinala, et al.
Pageof 1